Evaluating Evidence in In Vitro Fertilization Practices
Summary
Evaluating evidence in in vitro fertilization (IVF) practices encompasses a systematic appraisal of the efficacy, safety and cost-effectiveness of interventions within assisted reproductive technology. Central to this endeavour is the integration of evidence-based medicine principles, whereby interventions are classified according to the rigour of supporting data, most often derived from randomised controlled trials and well-conducted observational studies. Yet the rapid proliferation of so-called add-ons—ancillary treatments or technologies appended to standard IVF protocols—has posed challenges for clinicians, regulators and patients alike. These add-ons range from time-lapse embryo imaging to preimplantation genetic testing, and often command premium pricing despite limited demonstration of meaningful improvements in live birth rates. Further complexity arises from heterogeneous reporting of success metrics, with clinics varying widely in how they present pregnancy and live birth data. Commercial incentives and hybrid public–private care models have both driven and obfuscated the adoption of unvalidated treatments, underscoring the need for transparent communication of uncertainties and standardised outcome reporting. Globally, efforts to harmonise evidence standards and improve governance have become a priority to ensure patient-centred care and optimise resource allocation in fertility services.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Evaluating Evidence in In Vitro Fertilization Practices publication trend
The graph below shows the total number of articles in evaluating evidence in in vitro fertilization practices across all publications each year (not limited to Nature Index journals).
Technical terms
Add-on: An ancillary treatment or technological procedure offered in conjunction with standard IVF protocols, often without conclusive evidence of improved live birth outcomes.
Randomised Controlled Trial (RCT): A study design in which participants are randomly allocated to intervention or control groups to assess the causal effect of a treatment under controlled conditions.
Evidence-Based Medicine (EBM): A framework for clinical decision-making that integrates the best available research evidence with clinical expertise and patient values.
Success Rate Reporting: The presentation of IVF outcomes—such as pregnancy or live birth rates—often expressed with varying numerators and denominators, which can affect comparability across clinics.
Public–Private Hybrid Model: A care delivery framework in which patients access fertility treatments through both state-funded and privately funded routes, blurring traditional sector boundaries.
References
- Survey of in vitro fertilization add-ons in Japan (Izanami project). Frontiers in Endocrinology (2024).
- Is the use of IVF add-on treatments driven by patients or clinics? Findings from a UK patient survey. Human Fertility (2023).
- Medicine in the marketplace: clinician and patient views on commercial influences on assisted reproductive technology. Reproductive BioMedicine Online (2024).
- Direct-to-consumer advertising of success rates for medically assisted reproduction: a review of national clinic websites. BMJ Open (2017).
- The prevalence, promotion and pricing of three IVF add-ons on fertility clinic websites. Reproductive BioMedicine Online (2020).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.